Zevra Therapeutics (ZVRA) EBT Margin Growth (1y) (2020 - 2026)
Powered by 
Analysis
Zevra Therapeutics (ZVRA) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 553.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4,709.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,076.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1,911.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -392.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,565.00 |
| 10 | Zevra Therapeutics | 734.60 Mn | 513.03 Mn | 38.18 Mn | -26,471.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26,471.00 |
| Mar 31, 2026 | 13,310.00 |
| Dec 31, 2025 | 20,665.00 |
| Sep 30, 2025 | 89,423.00 |
| Jun 30, 2025 | 74,321.00 |
| Mar 31, 2025 | 47,796.00 |
| Dec 31, 2024 | -1,560.00 |
| Sep 30, 2024 | -54,599.00 |
| Jun 30, 2024 | -41,503.00 |
| Mar 31, 2024 | -6,796.00 |
| Dec 31, 2023 | -47,389.00 |
| Sep 30, 2023 | -12,064.00 |
| Jun 30, 2023 | 187,313.00 |
| Mar 31, 2023 | -37,228.00 |
| Dec 31, 2022 | 42,330.00 |
| Sep 30, 2022 | -14,183.00 |
| Jun 30, 2022 | -195,614.00 |
| Mar 31, 2022 | 3,786.00 |
| Dec 31, 2021 | 10,213.00 |
| Sep 30, 2021 | 6,856.00 |